MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

783.65 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 262
Open 783.65
Bid (Size) 773.25 (40)
Ask (Size) 798.25 (80)
Prev. Close 783.65
Today's Range 783.65 - 783.65
52wk Range 476.49 - 821.11
Shares Outstanding 91,779,465
Dividend Yield 0.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Regeneron Announces Investor Conference Presentations
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire

Performance

YTD
+0.9%
+0.9%
1 Month
+3.3%
+3.3%
3 Month
+12.8%
+12.8%
6 Month
+38.5%
+38.5%
1 Year
+18.0%
+18.0%

More News

Read More
News headline image
The Great Reversal: Tariffs Ignite Goods Inflation as Services Cool in Latest PCE Data
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
Regeneron Stock Slips Premarket Even After Wall Street Lifts Targets On Strong Q4 — What’s Weighing On The Stock? ↗
Via Stocktwits
Regeneron Pharmaceuticals (NASDAQ:REGN) Reports Q4 2025 Earnings Beat Amid Product Transition ↗
Via Chartmill
Topics Earnings
News headline image
Regeneron (REGN) Q1 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Supply Chain
News headline image
Regeneron (REGN) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Regeneron (REGN) Q4 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Regeneron (REGN) Q3 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
This $24 Million Buy Amid a 45% Stock Drop Signals Conviction in a High-Margin Data Business ↗
Via The Motley Fool
News headline image
Regeneron (REGN) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
These S&P500 stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
News headline image
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock ↗
Via Stocktwits
News headline image
Regeneron (NASDAQ:REGN) Posts Better-Than-Expected Sales In Q4 CY2025
Via StockStory
News headline image
Regeneron Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Earnings To Watch: Regeneron (REGN) Reports Q4 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
News headline image
2 Healthcare Stocks Poised for a Comeback in 2026 ↗
Via The Motley Fool
News headline image
GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics
Via MarketMinute
Topics Intellectual Property
News headline image
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗
Via MarketBeat
Topics ETFs
News headline image
3 Profitable Stocks We Think Twice About
Via StockStory
News headline image
1 Mooning Stock with Exciting Potential and 2 Facing Headwinds
Via StockStory
Topics Economy Energy
News headline image
Regeneron Just Moved From Underperform To Buy - Here's Why ↗
Via Benzinga
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
Why Regeneron (REGN) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 783.65
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 02/12/26 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 71.92B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 72B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story